Assessing the Inventiveness of Bio-Pharmaceuticals under European and US Patent Law: A comparative study with special emphasis on DNA- & protein-related inventions

Keyphrases

• US Patent Law 100%
• Inventiveness 100%
• European Patent 33%
• Biomedical Innovation 33%
• Actual Problem 33%
• Innovation Gap 33%
• Pharmaceutical Technology 33%
• Comprehensive Solution 33%
• Solution Model 33%
• Patent System 33%
• Pharmaceutical Sector 33%
• Protection Scope 33%
• Life Cycle Strategy 33%
• Related Patents 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Pharmaceutical Biotechnology 100%